Franklin Resources Inc Chimerix Inc Transaction History

Franklin Resources Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.94 - $1.23 $5,503 - $7,201	-5,855 Reduced 20.76%	22,342 $21,000
Q2 2023 Aug 11, 2023	SELL	$1.1 - $1.54 $64 - $90	-59 Reduced 0.21%	28,197 $34,000
Q4 2022 Feb 10, 2023	BUY	$1.67 - $2.35 $98 - $138	59 Added 0.21%	28,256 $52,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $644 - $982	356 Added 1.28%	28,197 $54,000
Q2 2022 Aug 11, 2022	SELL	$1.34 - $5.34 $18,076 - $72,036	-13,490 Reduced 32.64%	27,841 $58,000
Q1 2022 May 13, 2022	BUY	$4.58 - $6.8 $370 - $550	81 Added 0.2%	41,331 $189,000
Q4 2021 Feb 11, 2022	SELL	$5.23 - $7.18 $789 - $1,084	-151 Reduced 0.36%	41,250 $265,000
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $245,921 - $362,258	41,401 New	41,401 $256,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.